Schulze S, Schulze S, Schmidt J, Kroll P
Medizinisches Zentrum für Augenheilkunde an der Philipps-Universität Marburg, Robert-Koch-Strasse 4, 35033 Marburg.
Klin Monbl Augenheilkd. 2000 Dec;217(6):329-33. doi: 10.1055/s-2000-9570.
In patients with proliferative diabetic retinopathy rebleeding after pars plana vitrectomy is one of the most common complications. We tried to reduce the rate of that complication by using an air endotamponade.
The following study is a retrospective comparison of 2 patient groups both after pars plana vitrectomy due to proliferative diabetic retinopathy. Group 1 was managed with air as endotamponade (n = 52, mean age 61.2 years), group 2 without any endotamponade (n = 40, mean age 59.4 years). Classification of the proliferative diabetic retinopathy as described by Kroll et al. [5] in both groups: 23 and 29 patients with stage A resp., 24 and 10 patients with stage B resp., 5 and 1 patient with stage C respectively.
77% of group 1 patients had an increase os vision by mean of 4.8 vision steps, in 70% of the group 2 patients vision increased by mean of 7.2 vision steps. Complications in both groups as follows: Rebleeding within 14 days 15% vs. 33%, development of secondary glaucoma in 9.6% and 17.5% resp., revitrectomy within 14 days were necessary in 3.8% resp. 2.5% of the patients, later revitrectomy in 13.5% vs. 42.5% of all patients.
Air endotamponade turned out to be appropriate to reduce the rate of postoperative vitreous rebleeding after pars plana vitrectomy due to proliferative diabetic retinopathy. We found no increase of secondary glaucoma or cataract.
在增生性糖尿病视网膜病变患者中,玻璃体切除术后再出血是最常见的并发症之一。我们尝试通过使用空气内填塞来降低该并发症的发生率。
以下研究是对两组因增生性糖尿病视网膜病变行玻璃体切除术后患者的回顾性比较。第1组采用空气作为内填塞(n = 52,平均年龄61.2岁),第2组未进行任何内填塞(n = 40,平均年龄59.4岁)。两组增生性糖尿病视网膜病变的分类按照Kroll等人[5]的描述:A期分别为23例和29例患者,B期分别为24例和10例患者,C期分别为5例和1例患者。
第1组77%的患者视力平均提高4.8个视级,第2组70%的患者视力平均提高7.2个视级。两组并发症情况如下:14天内再出血发生率分别为15%和33%,继发性青光眼发生率分别为9.6%和17.5%,14天内需要再次玻璃体切除术的患者比例分别为3.8%和2.5%,后期再次玻璃体切除术在所有患者中的比例分别为13.5%和42.5%。
空气内填塞被证明适用于降低因增生性糖尿病视网膜病变行玻璃体切除术后的玻璃体再出血发生率。我们未发现继发性青光眼或白内障发生率增加。